Stock listing

NASDAQ:ALGS Aligos Therapeutics, Inc. Stock

Home listing (NASDAQ) of Aligos Therapeutics, Inc.

Follow Aligos Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ALGS

$1.22 USD -0.08 (-6.2%)

Close on Nov 20, 2026

Past year -85.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.18 – $1.34 USDNov 20, 2026
Volume
105,409 sharesNov 20, 2026
Market cap
$6.64M USDAt the close on Nov 20, 2026 · price × 5.44M shares outstanding
52-week range
$1.18 – $13.69 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$254,362 USDMedian day 42,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Aligos Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ALGS · Home$1.22 USD-0.08 (-6.2%)105,409$1.26$1.336$1.175$1.30Close on Nov 20, 2026
Frankfurt:5WK0€1.138 EUR-0.044 (-3.7%)190€1.106€1.138€1.106€1.182Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ALGS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.22-0.08-6.2%$1.26$1.336$1.175105,409
$1.30-0.06-4.4%$1.39$1.58$1.25109,147
$1.36-0.30-18.1%$1.63$1.63$1.3657,117
$1.66-0.44-21.0%$2.00$2.00$1.58139,603
$2.10+0.12+6.1%$2.09$2.245$1.9857,515
$1.98-0.18-8.3%$2.21$2.316$1.92120,576
$2.16-0.41-16.0%$2.79$2.81$2.02283,400
$2.57-1.38-34.9%$3.99$3.99$2.56194,200
$3.95-0.12-2.9%$4.25$4.65$3.95141,300
$4.07-0.44-9.8%$4.44$4.855$4.00101,700
$4.51-0.51-10.2%$5.004$5.004$4.50540,200
$5.02+0.27+5.7%$4.89$5.14$4.72127,800
$4.75+0.15+3.3%$4.65$4.95$4.6513,900
$4.60-0.20-4.2%$4.81$4.99$4.6023,000
$4.80-0.23-4.6%$4.99$5.05$4.7523,800
$5.03-0.14-2.7%$5.02$5.375$5.0247,200
$5.17+0.43+9.1%$4.66$5.26$4.6623,500
$4.74+0.09+1.9%$4.67$4.81$4.639,500
$4.65-0.13-2.7%$4.98$4.98$4.5533,000
$4.78-0.04-0.8%$4.76$4.92$4.654,800
$4.82-0.14-2.8%$5.005$5.005$4.7815,300
$4.96-0.07-1.4%$4.88$5.235$4.8813,100
$5.03+0.19+3.9%$4.74$5.241$4.7442,800
$4.84-0.02-0.4%$4.95$5.08$4.6182,000
$4.86-0.53-9.8%$5.32$5.50$4.8667,600
$5.39+0.16+3.1%$5.40$5.409$5.18625,500
$5.23-0.28-5.1%$5.50$5.60$5.2160,600
$5.51-0.02-0.4%$5.465$5.60$5.2034,000
$5.53+0.19+3.6%$5.50$5.64$5.3057,300
$5.34+0.03+0.6%$5.27$5.442$5.278,900
$5.31-0.01-0.2%$5.25$5.53$5.0837,400
$5.32-0.06-1.1%$5.33$5.525$5.2319,400
$5.38-0.02-0.4%$5.46$5.53$5.3112,800
$5.40-0.14-2.5%$5.57$5.65$5.3548,600
$5.54+0.04+0.7%$5.58$5.72$5.3729,000
$5.50-0.13-2.3%$5.69$5.74$5.36728,300
$5.63+0.01+0.2%$5.65$5.80$5.5435,300
$5.62+0.08+1.4%$5.53$5.68$5.4011,500
$5.54+0.03+0.5%$5.38$5.54$5.1879,500
$5.51-0.04-0.7%$5.70$5.765$5.4745,000
$5.55-0.01-0.2%$5.55$5.695$5.2759,600
$5.56-0.12-2.1%$5.72$5.936$5.4535,100
$5.68+0.19+3.5%$5.57$6.30$5.22275,700
$5.49+0.25+4.8%$5.31$5.88$5.21125,000
$5.24+0.07+1.4%$5.15$5.25$5.01521,300
$5.17+0.12+2.4%$5.10$5.29$5.1021,700
$5.05+0.06+1.2%$5.01$5.13$4.9341,700
$4.99-0.05-1.0%$5.04$5.445$4.8234,100
$5.04-0.18-3.4%$5.17$5.27$5.0228,000
$5.22-0.11-2.1%$5.39$5.502$5.1437,000
$5.33-0.17-3.1%$5.38$5.48$5.2146,100
$5.50-0.26-4.5%$5.79$6.02$5.4133,000
$5.76-0.45-7.2%$6.21$6.34$5.6263,600
$6.21-0.01-0.2%$6.16$6.21$6.0220,300
$6.22+0.01+0.2%$6.22$6.48$6.0742,100
$6.21+0.12+2.0%$6.15$6.64$6.0155,200
$6.09+0.23+3.9%$5.76$6.22$5.61101,600
$5.86-1.05-15.2%$6.83$6.83$5.8698,700
$6.91-0.16-2.3%$7.025$7.10$6.6439,100
$7.07-0.44-5.9%$7.44$7.495$6.8280,300
$7.51+0.04+0.5%$7.37$7.72$7.0468,900
$7.47+0.54+7.8%$6.93$7.538$6.7193,400
$6.93+0.26+3.9%$6.61$7.00$6.4033,200
$6.67+0.23+3.6%$6.48$6.799$6.4052,300
$6.44-0.45-6.5%$6.77$7.006$6.3562,500

Splits

1 split · NASDAQ:ALGS · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
Ticker
NASDAQ:ALGS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Aligos Therapeutics, Inc. news

Financings

  • Private placement of common stock, pre-funded warrants and accompanying warrants

    Feb 12, 2025

    Announced: about US$105M · US$26.0825 a share · Warrants at US$26.02 · Jefferies +2

    Dealers: Jefferies, Piper Sandler, H.C. Wainwright & Co.

    Use of proceeds: Advance ALG-000184 into a Phase 2 study in chronic hepatitis B and general corporate purposes

    Announced Feb 12, 2025

Read by 6ix AI from the company's releases

Decks

Aligos Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 135 in all · newest Nov 6, 2026 · oldest 2020
Decks
34 decks · latest March 2025

Where Aligos Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ALGS · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ALGSBOATSUnited StatesUSD
gettex:5WK0gettexGermanyEUR
LS Exchange:A40LQ4LS ExchangeGermanyEUR
Lang & Schwarz:A40LQ4Lang & SchwarzGermanyEUR
Tradegate:5WK0TradegateGermanyEUR
Dusseldorf:5WK0DusseldorfGermanyEUR
Frankfurt:5WK0FrankfurtGermanyEUR
Munich:5WK0MunichGermanyEUR
Stuttgart:5WK0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Aligos Therapeutics, Inc.